摘要
目的 建立冠脉宁片中化工染料检查及血竭素高氯酸盐含量测定方法。方法 采用高效液相色谱-串联质谱联用法(HPLC-MS/MS)对冠脉宁片中血竭药材可能存在的化工染料进行检查,并采用高效液相色谱法对其中的血竭素含量进行测定。化工染料检查使用色谱柱为:Agilent Zorbax-SB C18(4.6 mm×250 mm,5 μm),流动相为0.02 mol·L-1乙酸铵和乙腈的混合溶液,梯度洗脱,520 nm检测;质谱采用ESI+扫描,二级离子扫描方式。血竭素含量测定使用的色谱柱为Phenomenex Luna C18(4.6 mm×250 mm,5 μm)柱,流动相为乙腈-0.05 mol·L-1磷酸二氢钠溶液(37∶63),检测波长440 nm。结果 56批次样品中共有7批样品可检出苏丹红Ⅰ、Ⅳ以及808猩红等化工染料。血竭素高氯酸盐在0.408~816.6 μg·mL-1内有良好的线性关系,回归方程为y=1.746 1×107ρ+2 419.9,r=1.000 0;平均回收率为98.37% (RSD为1.2%,n=6)。56批次样品中血竭素含量在0.01~0.25 mg·片-1内。结论 所建立的方法简便,准确,快速,可用于冠脉宁片中血竭药材的质量控制。
Abstract
OBJECTIVE To establish METHODS for the test of chemical dyes and quantitative determination of dracorhodin perchlorate in Guanmaining tablets. METHODS HPLC-UV-MS/MS was used for the test of chemical dyes in Guanmaining tablets, and the concentration of dracorhodin perchlorate was determined by HPLC. In the test of chemical dyes, Agilent Zorbax-SB C18(4.6 mm×250 mm,5 μm) was used as stationary phase, the mixture of 0.02 mol·L-1 ammonium acetate and acetonitrile was used as mobile phase in gradient elution mode, and the UV-Vis detection wavelength was set at 520 nm. ESI+ was used as ion source, and the MS/MS spectra of the analytes were recorded to confirm the positive results. In the quantitative analysis of dracorhodin perchlorate, Phenomenex Luna C18(4.6 mm×250 mm,5 μm) was used as stationary phase, the mixture of acetonitrile and 0.05 mol·L-1 sodium dihydrogen phosphate solution (37∶63) was used as mobile phase, and the detection wavelength was set at 440 nm. RESULTS Among 56 batches of Guanmaining tablets, 7 batches showed positive RESULTS of sudan Ⅰ, sudan Ⅳ, and/or 808 scarlet. A good linear relationship was obtained in the range of 0.408 0-816.6 μg·mL-1 for dracorhodin perchlorate, with the linear regression equation of y=1.746 1×107ρ+2 419.9(r=1.000 0); the average recovery was 98.37%(RSD=1.2%, n=6). The content of dracorhodin perchlorate in Guanmaining tablets ranged from 0.01 to 0.25 mg·tablet-1. CONCLUSION The method is simple, accurate and rapid,and can be used for the quality control of Guanmaining tablets.
关键词
高效液相色谱法 /
高效液相色谱-紫外-串联质谱联用法 /
冠脉宁片 /
血竭 /
苏丹红Ⅰ /
苏丹红Ⅳ /
808猩红 /
血竭素高氯酸盐
{{custom_keyword}} /
Key words
HPLC /
HPLC-UV-MS/MS /
Guanmaining tablet /
Dracornis Sanguis /
sudan Ⅰ /
sudan Ⅳ /
808 scarlet /
dracorhodin perchlorate
{{custom_keyword}} /
何轶, 丁宁, 王瑞忠, 鲁静, 王栋, 张玉荣, 张聿梅, 戴忠.
冠脉宁片中化工染料检查及血竭素高氯酸盐含量测定研究[J]. 中国药学杂志, 2015, 50(2): 120-124 https://doi.org/10.11669/cpj.2015.02.008
HE Yi, DING Ning, WANG Rui-Zhong, LU Jing, WANG Dong, ZHANG Yu-Rong, ZHANG Yu-Mei, DAI Zhong.
Test of Chemical Dyes and Quantitative Determination of Dracorhodin Perchlorate in Guanmaining Tablets[J]. Chinese Pharmaceutical Journal, 2015, 50(2): 120-124 https://doi.org/10.11669/cpj.2015.02.008
中图分类号:
R917
{{custom_clc.code}}
({{custom_clc.text}})
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
Drug Specifications of Chinese Patent Medicine Promulgated by the Ministry of Public Health, P R China.,Vol 10 (卫生部药品标准中药成方制剂第十册).1995: 122.
Ch.P (2010) Vol Ⅰ(中国药典一部) .2010: 133.
YANG R R, LI S L. Identification of the adulterants of Dracornis Sanguis. Northwest Pharm J (西北药学杂志), 1987, 2 (2): 36-38.
HU H B. Analysis in the three alternation methods of Chinese medicinal materials and decoction pieces. Pharm Clin Res (药学与临床研究), 2012, 20(3): 261-263.
SU J, CHENG X L, ZHANG Y M, et al. Identification and determination of sudan IV in counterfeit drug of Sanguis draconiis . Chin Pharm Aff (中国药事), 2008, 22(4): 318-320.
LU S Y, ZHOU M Q. The hazards of frequent inedible colorants used in foods and their detection methods .Chin Instrument (中国仪器仪表), 2009, (8): 45.
ZHANG C Y, LI Z G, LEI L C. Studies on the identification and quantitation of Qianlieminiao suppository .Chin Pharm J (中国药学杂志), 2003, 38(5):373-375.
MIN C Y, FU L Y, WANG Q, et al. Experimental research of Carthami Flos adulteration. Chin Pharm Aff(中国药事), 2011, 25(8): 772-775.
RAO W W, JIANG L, ZHAO C Y, et al. Identification of chemical industry dyes in adulteration of Chinese medicinal materials. Chin J Pharm Anal (药物分析杂志), 2007, 27(11): 1742-1745.
{{custom_fnGroup.title_cn}}
脚注
{{custom_fn.content}}
基金
国家十二五“重大新药创制”专项(2014ZX09304307-002)
{{custom_fund}}